Copyright 2016 American Medical Association. All Rights Reserved.
Substandard and falsified medicines pose a serious threat to patient safety and public health.1 Studies on the quality of drugs have focused mainly on antimicrobial agents, such as antiretroviral therapy (for human immunodeficiency virus) and antimalarial medications.2 Although cardiovascular disease kills millions of Africans,3 to our knowledge, little published research has explored the quality of essential cardiovascular disease medicines to date. We therefore performed a quality assessment of 7 commonly used cardiac drugs (ie, an anticoagulant drug, a statin, and 5 antihypertensive drugs) in 10 countries of sub-Saharan Africa.
Antignac M, Diop BI, Do B, et al. Quality Assessment of 7 Cardiovascular Drugs in 10 Sub-Saharan CountriesThe SEVEN Study. JAMA Cardiol. 2017;2(2):223–225. doi:10.1001/jamacardio.2016.3851
Customize your JAMA Network experience by selecting one or more topics from the list below.